Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 564 | 287 | 221 | 621 | 208 |
| Cost of Goods | 364 | 171 | 139 | 410 | 299 |
| Gross Profit | 200 | 116 | 83 | 211 | -92 |
| Operating Expenses | 1,422 | 912 | 1,036 | 830 | 571 |
| Operating Income | -1,222 | -796 | -953 | -619 | -662 |
| Interest Expense | 30 | 24 | 47 | 41 | 21 |
| Other Income | 95 | -1 | 2,676 | 3 | 10 |
| Pre-tax Income | -1,157 | -822 | 1,675 | -657 | -673 |
| Net Income Continuous | -1,157 | -822 | 1,675 | -657 | -673 |
| Net Income | $-1,157 | $-822 | $1,675 | $-657 | $-673 |
| EPS Basic Total Ops | -0.01 | -0.01 | 0.02 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | 0.02 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | 0.02 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | 0.02 | -0.01 | -0.01 |
| EBITDA(a) | $-1,111 | $-784 | $1,735 | $-604 | $-634 |